Krystal Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.

About KRYS

Krystal Biotech, Inc. operates as a biotechnology company, which engages in discovery, development, manufacturing, and commercialization of pharmaceutical products. It offers the product, VYJUVEK. 

CEO
Krish S. Krishnan
CEOKrish S. Krishnan
Employees
295
Employees295
Headquarters
Pittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded
2016
Founded2016
Employees
295
Employees295

KRYS Key Statistics

Market cap
7.18B
Market cap7.18B
Price-Earnings ratio
35.88
Price-Earnings ratio35.88
Dividend yield
Dividend yield
Average volume
307.98K
Average volume307.98K
High today
$249.60
High today$249.60
Low today
$242.26
Low today$242.26
Open price
$248.11
Open price$248.11
Volume
289.70K
Volume289.70K
52 Week high
$298.30
52 Week high$298.30
52 Week low
$122.80
52 Week low$122.80

Stock Snapshot

Krystal Biotech(KRYS) stock is priced at $245.39, giving the company a market capitalization of 7.18B. It carries a P/E multiple of 35.88.

On 2026-03-29, Krystal Biotech(KRYS) stock traded between a low of $242.26 and a high of $249.60. Shares are currently priced at $245.39, which is +1.3% above the low and -1.7% below the high.

The Krystal Biotech(KRYS)'s current trading volume is 289.7K, compared to an average daily volume of 307.98K.

In the last year, Krystal Biotech(KRYS) shares hit a 52-week high of $298.30 and a 52-week low of $122.80.

In the last year, Krystal Biotech(KRYS) shares hit a 52-week high of $298.30 and a 52-week low of $122.80.

KRYS News

Simply Wall St 2d
Krystal Biotech Valuation Check After Recent Pullback And Mixed Earnings Multiple Signals

Advertisement Krystal Biotech: Stock Performance Context Krystal Biotech (KRYS) has drawn investor attention after a recent pullback, with the stock showing a...

Krystal Biotech Valuation Check After Recent Pullback And Mixed Earnings Multiple Signals
TipRanks 3d
Krystal Biotech initiated with a Peer Perform at Wolfe Research

Wolfe Research initiated coverage of Krystal Biotech (KRYS) with a Peer Perform rating and no price target Krystal is “performing well” commercially with Vyjuve...

Analyst ratings

92%

of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%

People also own

Based on the portfolios of people who own KRYS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.